BE'ER SHEVA, ISRAEL – Sept. 10, 2024 – MDClone, a leading data exploration and synthetic data company, today announced that it has hired Bruno Lempernesse, a 25-year veteran in healthcare technology, data science, and life sciences, as president with a primary focus on leading North American operations.

In his new position, Lempernesse will play a key role in driving MDClone's future growth and innovation with a strategic emphasis on North America. Most recently, Lempernesse served as chief executive officer at Carevive, recently acquired in May of 2024 by Health Catalyst. During his tenure, he propelled the company to transform the cancer care patient experience through data-driven solutions with pioneering work in real-world evidence, real-world data, and healthcare big data.

With a passion for data, research, and healthcare, Lempernesse has performed innovative work that focused on the early development and utilization of longitudinal patient data sourced from electronic medical records in Europe and the U.S.

"We are thrilled to welcome Bruno as our new president," said Ziv Ofek, Co-Founder & CEO, MDClone. "Bruno's extensive expertise and deep industry knowledge make him an invaluable addition to our team. He will play a pivotal role in elevating our ADAMS Centers and driving the expansion of our offerings, delivering comprehensive value to the life sciences sector and beyond."

“It is an honor to work with such a stellar group of healthcare technology professionals and experts as Ziv and his team have assembled,” said Lempernesse. "In a landscape dominated by data-driven challenges, I'm eager to collaborate with our distinguished partners to shift the paradigm from reactive improvement to proactive advancement, unlocking groundbreaking discoveries and innovations."


About MDClone
MDClone offers an innovative, self-service data exploration environment powering discovery and collaboration throughout healthcare ecosystems around the world. The MClone ADAMS Center accelerates grassroots, data-driven innovation by enabling front-line staff to ask their own questions of their organization’s data. Powered by the ADAMS Platform and protected by multilevel synthetic privacy capabilities, any user can engage in a dynamic and fluid process for data exploration, analysis, and action. Using synthetic data generation to collaborate across the healthcare ecosystem, MDClone customers accelerate research, improve operations and quality, and drive innovation to deliver better patient outcomes. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, Europe, and Israel. Visit mdclone.com for more information.

More People on the Move